Original language | English (US) |
---|---|
Article number | l4898 |
Journal | The BMJ |
Volume | 366 |
DOIs | |
State | Published - 2019 |
Externally published | Yes |
ASJC Scopus subject areas
- Medicine(all)
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
RoB 2 : A revised tool for assessing risk of bias in randomised trials. / Sterne, Jonathan A.C.; Savović, Jelena; Page, Matthew J.; Elbers, Roy G.; Blencowe, Natalie S.; Boutron, Isabelle; Cates, Christopher J.; Cheng, Hung Yuan; Corbett, Mark S.; Eldridge, Sandra M.; Emberson, Jonathan R.; Hernán, Miguel A.; Hopewell, Sally; Hróbjartsson, Asbjørn; Junqueira, Daniela R.; Jüni, Peter; Kirkham, Jamie J.; Lasserson, Toby; Li, Tianjing; McAleenan, Alexandra; Reeves, Barnaby C.; Shepperd, Sasha; Shrier, Ian; Stewart, Lesley A.; Tilling, Kate; White, Ian R.; Whiting, Penny F.; Higgins, Julian P.T.
In: The BMJ, Vol. 366, l4898, 2019.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - RoB 2
T2 - A revised tool for assessing risk of bias in randomised trials
AU - Sterne, Jonathan A.C.
AU - Savović, Jelena
AU - Page, Matthew J.
AU - Elbers, Roy G.
AU - Blencowe, Natalie S.
AU - Boutron, Isabelle
AU - Cates, Christopher J.
AU - Cheng, Hung Yuan
AU - Corbett, Mark S.
AU - Eldridge, Sandra M.
AU - Emberson, Jonathan R.
AU - Hernán, Miguel A.
AU - Hopewell, Sally
AU - Hróbjartsson, Asbjørn
AU - Junqueira, Daniela R.
AU - Jüni, Peter
AU - Kirkham, Jamie J.
AU - Lasserson, Toby
AU - Li, Tianjing
AU - McAleenan, Alexandra
AU - Reeves, Barnaby C.
AU - Shepperd, Sasha
AU - Shrier, Ian
AU - Stewart, Lesley A.
AU - Tilling, Kate
AU - White, Ian R.
AU - Whiting, Penny F.
AU - Higgins, Julian P.T.
N1 - Funding Information: disclosure form at www.icmje.org/coi_disclosure.pdf and declare: support from the MRC and Wellcome Trust for the submitted work; JACS reports grants from the MRC and NIHR during the conduct of the study; JS reports grants from the MRC, Cochrane Collaboration, and NIHR during the conduct of the study; CJC is one of the coordinating editors of Cochrane Airways and has responsibility for training Cochrane authors in the UK in Cochrane methodology (including the assessment of risks of bias); JRE reports grants from the MRC and Boehringer Ingelheim, outside the submitted work; MAH reports grants from the National Institutes of Health (NIH) during the conduct of the study; PJ serves as an unpaid member of the steering group of cardiovascular trials funded by Astra Zeneca, Biotronik, Biosensors, St Jude Medical, and The Medicines Company, has received research grants to the institution from Astra Zeneca, Biotronik, Biosensors International, Eli Lilly, and The Medicines Company, and honorariums to the institution for participation in advisory boards from Amgen, but has not received personal payments by any pharmaceutical company or device manufacturer; JJK reports personal fees from BMJ outside the submitted work; TLa is an employee of Cochrane; TLi reports grants from the NIH National Eye Institute, and the Patient-Centered Outcomes Research Institute during the conduct of the study; AM reports grants from MRC and Cancer Research UK during the conduct of the study; KT reports grants from MRC during the conduct of the study and personal fees from CHDI outside the submitted work; JPTH reports grants from the MRC and Cochrane Collaboration during the conduct of the study; the authors declare no other relationships or activities that could appear to have influenced the submitted work. Funding Information: The development of the RoB 2 tool was supported by the UK Medical Research Council (MRC) Network of Hubs for Trials Methodology Research (MR/L004933/2- N61), with the support of the host MRC ConDuCT-II Hub (Collaboration and innovation for Difficult and Complex randomised controlled Trials In Invasive procedures, MR/K025643/1), by MRC research grant MR/M025209/1, and by a grant from the Cochrane Collaboration. JACS, SME, and JPTH are National Institute for Health Research (NIHR) senior investigators. JACS, NSB, H-YC, BCR, and JPTH are supported by NIHR Bristol Biomedical Research Centre at University Hospitals Bristol NHS Foundation Trust and the University of Bristol. JACS, JPTH, and KT are members of the MRC Integrative Epidemiology Unit at the University of Bristol (supported by MRC grant MC-UU-00011/3) and the University of Bristol. JS, PFW, and JPTH are supported by the NIHR Collaboration for Leadership in Applied Health Research and Care West (CLAHRC West) at University Hospitals Bristol NHS Foundation Trust. PJ is a tier 1 Canada Research Chair in Clinical Epidemiology of Chronic Diseases supported by the Canada Research Chairs Programme. MJP was supported by an Early Career Fellowship from the Australian National Health and Medical Research Council (NHMRC 1088535). IRW was supported by the MRC Programme MC-UU-12023/21. Funding Information: Funding: The development of the RoB 2 tool was supported by the UK Medical Research Council (MRC) Network of Hubs for Trials Methodology Research (MR/L004933/2-N61), with the support of the host MRC ConDuCT-II Hub (Collaboration and innovation for Difficult and Complex randomised controlled Trials In Invasive procedures, MR/K025643/1), by MRC research grant MR/ M025209/1, and by a grant from the Cochrane Collaboration. JACS, SME, and JPTH are National Institute for Health Research (NIHR) senior investigators. JACS, NSB, H-YC, BCR, and JPTH are supported by NIHR Bristol Biomedical Research Centre at University Hospitals Bristol NHS Foundation Trust and the University of Bristol. JACS, JPTH, and KT are members of the MRC Integrative Epidemiology Unit at the University of Bristol (supported by MRC grant MC_UU_00011/3) and the University of Bristol. JS, PFW, and JPTH are supported by the NIHR Collaboration for Leadership in Applied Health Research and Care West (CLAHRC West) at University Hospitals Bristol NHS Foundation Trust. PJ is a tier 1 Canada Research Chair in Clinical Epidemiology of Chronic Diseases supported by the Canada Research Chairs Programme. MJP was supported by an Early Career Fellowship from the Australian National Health and Medical Research Council (NHMRC 1088535). IRW was supported by the MRC Programme MC_UU_12023/21. The views expressed in this article are those of the authors and do not necessarily represent those of the UK National Health Service, NIHR, MRC, or Department of Health and Social Care, or the Australian NHMRC. Development of the RoB tool, writing the paper and the decision to submit for publication were independent of all research funders.
PY - 2019
Y1 - 2019
UR - http://www.scopus.com/inward/record.url?scp=85071628750&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85071628750&partnerID=8YFLogxK
U2 - 10.1136/bmj.l4898
DO - 10.1136/bmj.l4898
M3 - Article
C2 - 31462531
AN - SCOPUS:85071628750
VL - 366
JO - British Medical Journal
JF - British Medical Journal
SN - 0959-8146
M1 - l4898
ER -